Novacyt S.A. (AIM:NCYT)
London · Delayed Price · Currency is GBP · Price in GBX 39.90
-0.20 (-0.50%)
Oct 31, 2025, 4:10 PM GMT+1
Novacyt Market Cap
Novacyt has a market cap or net worth of 27.87 million as of October 31, 2025. Its market cap has decreased by -30.78% in one year.
Market Cap
27.87M
Enterprise Value
14.79M
Revenue
19.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.90
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 18.97M to 27.87M, an increase of 46.90%. That is a compound annual growth rate of 2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 27.87M | -20.65% |
| Dec 31, 2024 | 35.12M | -19.57% |
| Dec 29, 2023 | 43.67M | -43.27% |
| Dec 30, 2022 | 76.97M | -70.37% |
| Dec 31, 2021 | 259.78M | -58.11% |
| Dec 31, 2020 | 620.07M | 7,360.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.55B |
| GSK plc | 71.65B |
| Haleon | 31.24B |
| Smith & Nephew | 11.59B |
| ConvaTec Group | 4.84B |
| Hikma Pharmaceuticals | 4.04B |
| HUTCHMED (China) | 1.88B |
| Genus | 1.66B |